Evidence map›Paper›PMID 34981409›Full record

ArticleIn vitro cellular & developmental biology. Animal2022

Generation of a 3D melanoma model and visualization of doxorubicin uptake by fluorescence imaging.

Dora Domnica Baciu, Andrei Mihai Dumitrașcu, Valentin Vasile, Bianca Palade, Aurora Sălăgeanu

Abstract read
PubMed Publisher
In one paragraph

Article in In vitro cellular & developmental biology. Animal, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.7field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Enhancing Transcutaneous Drug Delivery: Advanced Perspectives on Skin Models.JID innovations : skin science from molecules to population health · 2025
    Review
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Dora Domnica BaciuCantacuzino National Medical-Military Institute for Research and Development, 103 Spl. Independentei, 050096, Bucharest, Romania. popescudoradomnica@yahoo.com.ORCID http://orcid.org/0000-0002-6668-4121
Andrei Mihai DumitrașcuCantacuzino National Medical-Military Institute for Research and Development, 103 Spl. Independentei, 050096, Bucharest, Romania.
Valentin VasileCantacuzino National Medical-Military Institute for Research and Development, 103 Spl. Independentei, 050096, Bucharest, Romania.
Bianca PaladeCantacuzino National Medical-Military Institute for Research and Development, 103 Spl. Independentei, 050096, Bucharest, Romania.
Aurora SălăgeanuCantacuzino National Medical-Military Institute for Research and Development, 103 Spl. Independentei, 050096, Bucharest, Romania.
Institutul Cantacuzino · RO

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Melanoma is the most dangerous type of skin cancer and is responsible for 75% of deaths from skin cancers. For an accurate evaluation of potential treatment efficacy, it is important to use study models as close as possible to the in vivo conditions. A 3D model consisting of B16F10 spheroids was developed using liquid overlay technique on plates coated with 1% agarose, in the presence of 1% methylcellulose and L929-conditioned medium. The model is suitable and can be further used for more complex in vitro drug testing than the classical 2D approach. For exemplification, the behavior of a well-known cytostatic, doxorubicin (DOX), was evaluated in spheroids as compared to classical 2D culture conditions. Fluorescence imaging was used to visualize DOX uptake by B16F10 spheroids at different periods of time. The results showed that a much higher DOX concentration is necessary to produce similar effects compared with the monolayer. The fluorescence images revealed that at least 4 h of stimulation is needed for a sufficient DOX uptake. The 3D model developed in this study was suitable to investigate drug penetration in time. Our findings may explain the decrease of the doxorubicin therapeutical effect, suggesting the need of maintaining the drug concentration at the tumoral place for at least 2 h upon administration. Similar or more advanced studies can lead to a better understanding of drug delivery kinetics and distribution upon administration, conducing toward a better performance in designing suitable delivery systems for obtaining the optimum dose-response effect.

Indexed as

MelanomaSpheroids, CellularAnimalsCell Line, TumorDoxorubicinOptical ImagingDoxorubicin3D modelB16F10 spheroidsDoxorubicinDrug resistanceFluorescence imaging

Identifiers

PMID34981409
OpenAlexW4206190957

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.